sound science

sound science

We’ve accelerated drug discovery through well-orchestrated research and sound science. We are on a mission to improve the lives of patients with over a dozen programs in our pipeline.

Aria Pharmaceuticals is a preclinical-stage pharmaceutical company discovering and developing novel small molecule therapies for complex and hard-to-treat diseases. Too many patients today are in need of breakthrough treatments across many complicated diseases – they can’t wait. That’s why at Aria, we have redefined the drug discovery approach, saving years in the process and increasing success rates 30 times higher than traditional methods. At Aria, we’ve shown promise across a diverse range of therapeutic areas with the ability to address over 1,000 diseases.
MOAs icon

Novel, first-in-class MOAs

18 diseases icon

A pipeline spanning over a dozen therapeutic areas

in vivo icon

30x hit rate at in vivo efficacy milestones

years icon

Saves years in drug development

OUR SCIENCE & PIPELINE

Sound science requires discipline. There are no shortcuts. We take a rigorous approach to identifying new disease targets and evaluating novel treatments for safety and efficacy. By combining the science of biology and the science of technology, we are efficiently growing our pipeline to address today’s most complex diseases where new therapies are needed the most.
oncology icon

Oncology

immunity icon

Immune/Inflammatory

fibrosis icon

Fibrotic

metabolic icon

Metabolic

other icon

Other

latest updates

hear from aria

About Us

Science & Pipeline

Partnerships

News & Events

Careers